Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. (600436) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.

Why is Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. ?

With a fall in Net Sales of -28.56%, the company declared Very Negative results in Mar 25

OPERATING CASH FLOW(Y) Lowest at CNY 1,735.5 MM
ROCE(HY) Lowest at 20.29%
CASH AND EQV(HY) Lowest at CNY 6,401.74 MM

With ROE of 18.44%, it has a very expensive valuation with a 8.09 Price to Book Value

Over the past year, while the stock has generated a return of -26.75%, its profits have fallen by -10.2%
At the current price, the company has a high dividend yield of 1.5

Below par performance in long term as well as near term

Along with generating -26.75% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.

-26.75%

-1.72

14.75%

China Shanghai Composite

14.77%

1.01

14.58%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

11.63%

EBIT Growth (5y)

12.96%

EBIT to Interest (avg)

84.28

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.03

Sales to Capital Employed (avg)

0.69

Tax Ratio

15.18%

Dividend Payout Ratio

60.19%

Pledged Shares

Institutional Holding

ROCE (avg)

43.04%

ROE (avg)

21.78%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

8.09

EV to EBIT

37.45

EV to EBITDA

36.08

EV to Capital Employed

10.82

EV to Sales

10.93

PEG Ratio

Dividend Yield

1.52%

ROCE (Latest)

28.88%

ROE (Latest)

18.44%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company

INTEREST COVERAGE RATIO(Q)

Highest at 15,998.03

NET SALES(Q)

At CNY 3,118.7 MM has Grown at 16.39%

PRE-TAX PROFIT(Q)

Highest at CNY 1,186.07 MM

NET PROFIT(Q)

Highest at CNY 1,006.32 MM

EPS(Q)

Highest at CNY 1.66

-9What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 1,735.5 MM

ROCE(HY)

Lowest at 20.29%

CASH AND EQV(HY)

Lowest at CNY 6,401.74 MM

DEBT-EQUITY RATIO (HY)

Highest at -1.77 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.43%

DEBTORS TURNOVER RATIO(HY)

Lowest at 9.67%

Here's what is working for Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.

Interest Coverage Ratio

Highest at 15,998.03

in the last five periods

MOJO Watch

The company's ability to manage interest payments is improving

Operating Profit to Interest

Net Sales

At CNY 3,118.7 MM has Grown at 16.39%

over average net sales of the previous four periods of CNY 2,679.62 MM

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Pre-Tax Profit

Highest at CNY 1,186.07 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 1,006.32 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 1.66

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Here's what is not working for Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.

Operating Cash Flow

Lowest at CNY 1,735.5 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Cash and Eqv

Lowest at CNY 6,401.74 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio

Highest at -1.77 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio

Lowest at 1.43%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio

Lowest at 9.67%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio